Congress trade

Rep. Bradley Schneider (D-IL) sold $100K-$250K of Celgene Corporation (CELG) stock

STOCK Act disclosure · Filed Oct 29, 2017

Bradley Schneider, U.S. Representative (D-IL), disclosed a sale of Celgene Corporation (CELG) stock worth $100K-$250K in a STOCK Act filing on Oct 29, 2017.

The trade happened on Oct 23, 2017, 6 days before it was made public.

Sold

CELG

Celgene Corporation

Disclosed range

$100K-$250K

Traded: Oct 23, 2017
Disclosed: Oct 29, 2017
Filing delay: 6 days
Source: STOCK Act disclosure

See the filing

Other trades in this disclosure (9)

SellCCL$100K-$250KOct 29, 2017
SellCELG$100K-$250KOct 29, 2017
BuyINTC$100K-$250KOct 29, 2017
BuyJPM$100K-$250KOct 29, 2017
BuyJPM$100K-$250KOct 29, 2017
BuyLEN$100K-$250KOct 29, 2017
SellLEN$100K-$250KOct 29, 2017
BuyPX$100K-$250KOct 29, 2017
SellVMC$100K-$250KOct 29, 2017

Share this trade

From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.